The cost-effectiveness of bevacizumab in combination with paclitaxel in first-line treatment of patients with metastatic breast cancer.
A. J. Montero
No relevant relationships to disclose
S. Gluck
Consultant or Advisory Role - Genentech
Research Funding - Genentech
G. d. L. Lopes
Research Funding - Genentech; Roche